Big Pharma Takes Another Haircut As China Slashes Drug Prices In Two Largest Therapy Fields
This article was originally published in The Pink Sheet Daily
Executive Summary
In the latest round of price cuts announced this week, Pfizer Inc. (combined with Wyeth) took the biggest hit, with 17 products seeing prices slashed.